Wound Management Market Segment Growth, 2008-2017

Excerpt from MedMarket Diligence report #S245, “Worldwide Wound Management, 2007-2016.”  See link for more information. Available for purchase online.

Wound Management Market Growth by Segments, 2007-2016Technologies developed and in use for the management of acute and chronic wounds have diversified from traditional dressings, bandages and wound closure techniques to include an increasing number of diverse technologies ranging from tissue engineering, growth factors, physical therapies (e.g., negative pressure) and others.Traditional dressings and bandages have evolved to contain more active elements contributing to wound healing, with products including films, hydrocolloids, foams, alginates, hydrogels, non-adherents and antimicrobials.  Wound closure is a specific area of intense development and market growth beyond traditional suturing and more recent stapling technologies and has seen proliferation and high market growth for surgical sealants, glues and hemostasis products.

The size of the worldwide wound management market is ultimately driven by the clinical need for advanced wound management products. That need is most clearly reflected in the prevalence of chronic wounds and burns. Current estimates put the total annual incidence of chronic wounds at almost 9 million worldwide, and there are 177 million cases of diabetes worldwide; 10-15% of diabetic patients will develop ulcers at some point. The market for products used in the management of venous stasis (as in chronic venous ulcers) is put at over $3 billion, while the decubitus ulcer (e.g., bedsores) market is in excess of $2 billion. Sales of products used to treat diabetic foot ulcers are estimated around $1.5 billion, and the market for burns dressings is approximately $60 million.

It should be noted that a large proportion of worldwide wound product sales are accounted for by traditional types of wound management products. An estimated two-thirds of the world’s physicians are not making routine use of advanced wound management products, with availability playing only a minor role in limiting their use. Conversely, while the U.S. healthcare market is characterized by an almost overindulgent attitude toward new technologies, U.S. physicians are much more conservative in their approach to advanced wound healing technologies than their European counterparts. For this reason, the European share of the advanced wound care market is significantly higher than the U.S. share.

Market Growth in Wound Management Product Segments
Until recently, the product categories with most growth potential were alginates and foams; both have substantial shares of the total market and both are set to increase their shares substantially between 2007 and 2016. Hydrocolloids had a considerable market share in 2007 but their star is in decline; it is anticipated that they will lose several percentage points in the market share table by 2016. (Segment growth in chart from MedMarket Diligence report #S245, “Worldwide Wound Management, 2007-2016,” publishing November 2007. See link for description, table of contents.)

The most significant market entrants are growth factors and, even more dramatically, physical therapies — specifically, negative pressure (also known as VAC therapy) devices. This market sector grew from a small base to gain $1.2 billion by 2007 and is set to capture an estimated 20% of the advanced woundcare market by 2016.

Films, antimicrobials and non-adherent dressings will maintain steady growth although their shares of a vigorously expanding market will decline.

(Report #S245, “Worldwide Wound Management” is available for purchase online.)

8 thoughts on “Wound Management Market Segment Growth, 2008-2017”

  1. Really nice blog.
    Dear M. Driscoll, you wrote above “the market for burns dressings is approximately $60 million.”, Do you speak only about the hospitalized patients (3rd degree or large 2nd degree) or as well for the medically treated patients? This number seems tiny in comparison with the ulcer’s market. Thanks a lot!

  2. Thank you for your comments. On your question, the burns dressings market is for hospitalized patients and for patients treated in other clinical settings (doctors’ offices, outpatient centers and similar). Regarding a comparison between burns and ulcers (but note that we do not have an estimate in this post about the ulcers “market”), the difference ensues largely from both the fact that there are far more causes to ulcers and the fact that the chronic nature of ulcers drives a higher volume of treatments.

  3. Thank you for your quick answer.
    If we have a look to the burns Worldwide prevalence that you describe in this post:


    There is about 10 million (3.4M for Burn wounds (outpatient) + 6.5M for Burn wounds (medically treated) + 0.2 M for Burn wounds (hospitalized)) of burns per year which gives the same order of magnitude as for the 3 kinds of ulcers (8.5M Pressure ulcers, 12.5M for Venous ulcers and 13.5M Diabetic ulcers per year). I understand that the chronic nature of ulcers drives a higher volume of treatments but I was not expecting this difference in the size of the market. This is why I was thinking that the above “$60 million market” was related to the Burn wounds (hospitalized) group (0.2 M/year).

    According to some articles (http://www.pr.com/press-release/254148), the worldwide wound care market revenues are around $15 billion. Does it means that Acute Wounds (such as Surgical wounds, Traumatic wounds and Lacerations) represent around half of the Wound Care Markets?

    I’m not sure to understand this point: “but note that we do not have an estimate in this post about the ulcers “market”.
    When you wrote “Sales of products used to treat diabetic foot ulcers are estimated around $1.5 billion”. Is it not an estimate about the products sold in order to treat diabetic foot ulcers? And thus an estimation of the diabetic foot ulcers market? and the same for the other kinds of ulcers.

    Thanks a lot for your answer and sorry for the extensive comment…

  4. First, you are correct and I was mistaken regarding the estimate of the ulcer market — in my effort to be quick to respond, I had considered only the market data table in that post and not the text that did indeed provide our estimate of the global (skin) ulcer treatment market. As for your suggestion that acute wounds represent about half of the overall wound care market, that is probably true, since on a prevalence basis chronic wounds represent about a third of the overall number of patients but also represent a higher share of overall revenues since ulcers (being chronic) require more product for healing. On the other side, burns represent a fairly small share of the total, but on the order of a $60 million market for treatment of burns versus about $5.2 billion overall (in 2008, the time point for data in this post).

  5. Thank you for responding my previous questions.
    What is “$5.2 billion overall”? Which overall? I do not find/understand this number sorry.
    Again, thank you for your blog. It has been a great help for me.

  6. Thank you for your questions. It is good to see a reader paying attention to the details to such extent as to help clarify our posts.

    On the $5.2 overall, I mean the worldwide market for wound management in 2008, the time point of that original post. See: Worldwide wound management market, by segment, 2008 and 2017

  7. Thanks for the graph. But how is it possible that the worldwide market for wound management in 2008 (5.2 billion) is lower than the sum of the different ulcers market (3 + 2 + 1.5 billion ; which are a part of the market for wound management I guess)?
    If I refer to your graph, perhaps 5.2 billion is the worldwide market for “Advanced” wound management in 2008 which is part of the worldwide market for wound management (estimated to $15 billion in 2010)?
    If yes, do you know the distribution by segment for non-advanced wound management market?

  8. As you surmised, our report was focused only on the “advanced” wound management market. There remains a much larger market for traditional dressings and bandages that is not part of this analysis. I can’t speak to what that total is — the $15 billion you quote is an estimate from a different source whose methodologies, sources and reliability I have no way of assessing. As to what I would put that number at, it is not something I would conclude without a thorough analysis.

Leave a Reply